STOCKHOLM (EGMN) - Patients aged 71 years and older with advanced non-small cell lung cancer showed significantly greater survival with carboplatin chemotherapy plus concurrent radiation than with radiotherapy alone in a Japan Clinical Oncology Group trial that included only elderly patients. Median overall survival was significantly longer, at 22.4 months, for those who received chemoradiotherapy, compared with 16.9...